We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Sekisui XenoTech Announces Creation of Scientific Advisory Board (SAB)

Product News   Jan 06, 2019

 
Sekisui XenoTech Announces Creation of Scientific Advisory Board (SAB)

Dr. Brian Ogilvie, Vice President of Scientific Consulting for Sekisui XenoTech

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Horizon Discovery Expands Cell-based CRISPR Screening Services

Product News

Horizon Discovery has announced the addition of an arrayed CRISPR knockout screening service for primary human B cells to its cell-based screening services.

READ MORE

New Collaboration Aims to Increase COVID-19 Reagent Production

Product News

OXGENE™ and The Native Antigen Company have announced a collaboration to scale up their antigen manufacturing capabilities to deliver high-purity, recombinant proteins for the development of diagnostics and vaccines.

READ MORE

Neoantigen Specific Peptide Synthesis Service for Precision Immuno-oncology Therapeutic Development

Product News

The new service from GenScript aims to overcome the challenges of manufacturing difficult neoantigen peptides critical to personalized cancer vaccine and T-cell therapy generation.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE